NovoCure Limited Long-Term Debt
NovoCure Limited (NVCR) had Long-Term Debt of $195.05 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:LongTermDebtNoncurrent · last filed 2026-02-26
- 2025-12-31: Long-term Debt, Excluding Current Maturities $195.05M.
- 2024-12-31: Long-term Debt, Excluding Current Maturities $97.30M.
- 2024-03-31: Long-term Debt, Excluding Current Maturities $569.65M.
- 2023-12-31: Long-term Debt, Excluding Current Maturities $568.82M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2025-12-31 | $195.05M 10-K · filed 2026-02-26 |
| 2024-12-31 | $97.30M 10-K · filed 2026-02-26 |
| 2024-03-31 | $569.65M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $568.82M 10-K · filed 2025-02-27 |
| 2023-09-30 | $567.99M 10-Q · filed 2023-10-26 |
| 2023-06-30 | $567.15M 10-Q · filed 2023-07-27 |
| 2023-03-31 | $566.32M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $565.51M 10-K · filed 2024-02-22 |
| 2022-09-30 | $564.68M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $563.85M 10-Q · filed 2022-07-28 |
| 2022-03-31 | $563.03M 10-Q · filed 2022-04-28 |
| 2021-12-31 | $562.22M 10-K · filed 2023-02-23 |
| 2021-09-30 | $561.39M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $560.56M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $559.58M 10-Q · filed 2021-04-29 |
| 2020-12-31 | $429.90M 10-K · filed 2022-02-24 |
| 2020-09-30 | $0.00 10-Q · filed 2020-10-29 |
| 2020-06-30 | $149.51M 10-Q/A · filed 2020-10-02 |
| 2020-03-31 | $149.47M 10-Q/A · filed 2020-10-02 |
| 2019-12-31 | $149.42M 10-K · filed 2021-02-25 |
| 2019-09-30 | $149.38M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $149.34M 10-Q · filed 2019-07-25 |
| 2019-03-31 | $149.31M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $149.27M 10-K · filed 2020-02-27 |
| 2018-09-30 | $149.23M 10-Q · filed 2018-10-25 |
| 2018-06-30 | $149.19M 10-Q · filed 2018-07-26 |
| 2018-03-31 | $149.16M 10-Q · filed 2018-04-26 |
| 2017-12-31 | $97.34M 10-K · filed 2019-02-28 |
| 2017-09-30 | $97.05M 10-Q · filed 2017-10-26 |
| 2017-06-30 | $96.77M 10-Q · filed 2017-07-27 |
| 2017-03-31 | $96.49M 10-Q · filed 2017-04-27 |
| 2016-12-31 | $96.23M 10-K · filed 2018-02-22 |
| 2016-09-30 | $95.97M 10-Q · filed 2016-11-02 |
| 2016-06-30 | $23.29M 10-Q · filed 2016-07-28 |
| 2016-03-31 | $23.19M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $23.10M 10-K · filed 2017-02-23 |
| 2015-09-30 | $24.55M 10-Q · filed 2015-10-27 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |